This site is new - feedback and suggestions welcome via GitHub issues.

#obesity — Thursday, November 20, 2025 (1 items)

hot top new auto
← prev day next day →
0 ℹ Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial. (linkinghub.elsevier.com) robot Horn DB … Jouravskaya I The Lancet 2025-11-20 #metabolism #clinical trial #diabetes #pharmacotherapy #obesity